| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8775655 | Urology | 2018 | 5 Pages |
Abstract
DNA contamination in unstained tissue sections sent for prognostic prostate cancer molecular diagnostic testing occurs in 2.3% of the cases, and can be of a magnitude that affects the results and subsequent clinical decision of appropriateness for active surveillance.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Lathem Wojno, Caitlyn Minutella, Donald Moylan, Arla Bush, Kirk Wojno,